Bioqual BIOQ Stock
Bioqual Price Chart
Bioqual BIOQ Financial and Trading Overview
| Bioqual stock price | 32.5 USD |
| Previous Close | 35 USD |
| Open | 35 USD |
| Bid | 32.5 USD x 150000 |
| Ask | 35 USD x 30000 |
| Day's Range | 35 - 35 USD |
| 52 Week Range | 32.5 - 45 USD |
| Volume | 103 USD |
| Avg. Volume | 44 USD |
| Market Cap | 31.3M USD |
| Beta (5Y Monthly) | -0.062 |
| PE Ratio (TTM) | 17.073172 |
| EPS (TTM) | 2.05 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | October 7, 2024 |
| 1y Target Est | N/A |
BIOQ Valuation Measures
| Enterprise Value | 49.25M USD |
| Trailing P/E | 17.073172 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.73924196 |
| Price/Book (mrq) | 0.8940203 |
| Enterprise Value/Revenue | 1.163 |
| Enterprise Value/EBITDA | -1219.662 |
Trading Information
Bioqual Stock Price History
| Beta (5Y Monthly) | -0.062 |
| 52-Week Change | -27.77% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 45 USD |
| 52 Week Low | 32.5 USD |
| 50-Day Moving Average | 36.59 USD |
| 200-Day Moving Average | 38.58 USD |
BIOQ Share Statistics
| Avg. Volume (3 month) | 44 USD |
| Avg. Daily Volume (10-Days) | 270 USD |
| Shares Outstanding | 894.42K |
| Float | 205.67K |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.5 |
| Trailing Annual Dividend Yield | 1.42% |
| 5 Year Average Dividend Yield | 119.00% |
| Payout Ratio | 0.1463 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2025 |
| Most Recent Quarter (mrq) | February 28, 2026 |
| Next Fiscal Year End | May 31, 2026 |
Profitability
| Profit Margin | -2.91% |
| Operating Margin (ttm) | -12.60% |
| Gross Margin | 19.06% |
| EBITDA Margin | -0.095% |
Management Effectiveness
| Return on Assets (ttm) | -2.23% |
| Return on Equity (ttm) | -3.46% |
Income Statement
| Revenue (ttm) | 42.35M USD |
| Revenue Per Share (ttm) | 47.35 USD |
| Quarterly Revenue Growth (yoy) | -29.89% |
| Gross Profit (ttm) | 8.07M USD |
| EBITDA | -40381 USD |
| Net Income Avi to Common (ttm) | -1235298 USD |
| Diluted EPS (ttm) | 2.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.29M USD |
| Total Cash Per Share (mrq) | 14.86 USD |
| Total Debt (mrq) | 33.48M USD |
| Total Debt/Equity (mrq) | 95.61 USD |
| Current Ratio (mrq) | 4.012 |
| Book Value Per Share (mrq) | 39.149 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.28M USD |
| Levered Free Cash Flow (ttm) | 12.06M USD |
Profile of Bioqual
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 9620 Medical Center Drive |
| ZIP | 20850 |
| Phone | 240 404 7654 |
| Website | https://www.bioqual.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides contract research services in the areas of AIDS, influenza, respiratory syncytial virus, Coronavirus, malaria, hepatitis, cancer, and other infectious diseases, as well as flavivirus infections, including zika and dengue. It also offers small and large animal models. In addition, the company provides cell-based assays, immunoassay, toxicology and cytotoxicity testing, viral load testing, and tailored assay development services; and Biocontainment, imaging services, and animal model development; and IND-enabling services, such as toxicology studies, pharmacokinetic profiling, GLP services, and regulatory documentation services. Bioqual, Inc. was incorporated in 1981 and is based in Rockville, Maryland.
Q&A For Bioqual Stock
What is a current BIOQ stock price?
Bioqual BIOQ stock price today per share is 32.5 USD.
How to purchase Bioqual stock?
You can buy BIOQ shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioqual?
The stock symbol or ticker of Bioqual is BIOQ.
Which industry does the Bioqual company belong to?
The Bioqual industry is Diagnostics & Research.
How many shares does Bioqual have in circulation?
The max supply of Bioqual shares is 894.42K.
What is Bioqual Price to Earnings Ratio (PE Ratio)?
Bioqual PE Ratio is 15.85365900 now.
What was Bioqual earnings per share over the trailing 12 months (TTM)?
Bioqual EPS is 2.05 USD over the trailing 12 months.
Which sector does the Bioqual company belong to?
The Bioqual sector is Healthcare.